United States Chemotherapy Market Report 2016

September 2016 | 119 pages | ID: UC6DEB4DA26EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Chemotherapy

Revenue, means the sales value of Chemotherapy

This report studies sales (consumption) of Chemotherapy in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer Inc. (USA)
• Abbott Laboratories (USA)
• Genentech Inc. (USA)
• GlaxoSmithKline Plc (UK)
• Immunomedics, Inc. (USA)
• Indevus Pharmaceuticals Inc. (USA)
• Novartis AG (Switzerland)
• OSI Pharmaceuticals, Inc. (USA)
• Paladin Labs Inc. (Canada)
• ALZA Corporation (USA)
• Amgen Inc. (USA)
• AstraZeneca PLC (UK)
• Medimmune, LLC (USA)
• Bristol-Myers Squibb Company (USA)
• Cell Genesys Inc. (USA)
• Dendreon Corporation (USA)
• EUSA Pharma, (USA) Inc. (USA)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Progenics Pharmaceuticals, Inc. (USA)
• Sanofi-Aventis SA (France)
• Spectrum Pharmaceuticals, Inc. (USA)
• Takeda Pharmaceutical Company Limited (Japan)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Chemotherapy in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Chemotherapy Market Report 2016

1 CHEMOTHERAPY OVERVIEW

1.1 Product Overview and Scope of Chemotherapy
1.2 Classification of Chemotherapy
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Chemotherapy
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Chemotherapy (2011-2021)
  1.4.1 USA Chemotherapy Sales and Growth Rate (2011-2021)
  1.4.2 USA Chemotherapy Revenue and Growth Rate (2011-2021)

2 USA CHEMOTHERAPY COMPETITION BY MANUFACTURERS

2.1 USA Chemotherapy Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Chemotherapy Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Chemotherapy Average Price by Manufactures (2015 and 2016)
2.4 Chemotherapy Market Competitive Situation and Trends
  2.4.1 Chemotherapy Market Concentration Rate
  2.4.2 Chemotherapy Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA CHEMOTHERAPY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Chemotherapy Sales and Market Share by Type (2011-2016)
3.2 USA Chemotherapy Revenue and Market Share by Type (2011-2016)
3.3 USA Chemotherapy Price by Type (2011-2016)
3.4 USA Chemotherapy Sales Growth Rate by Type (2011-2016)

4 USA CHEMOTHERAPY SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Chemotherapy Sales and Market Share by Application (2011-2016)
4.2 USA Chemotherapy Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA CHEMOTHERAPY MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer Inc. (USA)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Chemotherapy Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Abbott Laboratories (USA)
  5.2.2 Chemotherapy Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Abbott Laboratories (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Genentech Inc. (USA)
  5.3.2 Chemotherapy Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Genentech Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 GlaxoSmithKline Plc (UK)
  5.4.2 Chemotherapy Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 GlaxoSmithKline Plc (UK) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Immunomedics, Inc. (USA)
  5.5.2 Chemotherapy Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Immunomedics, Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Indevus Pharmaceuticals Inc. (USA)
  5.6.2 Chemotherapy Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Indevus Pharmaceuticals Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Novartis AG (Switzerland)
  5.7.2 Chemotherapy Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Novartis AG (Switzerland) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 OSI Pharmaceuticals, Inc. (USA)
  5.8.2 Chemotherapy Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 OSI Pharmaceuticals, Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Paladin Labs Inc. (Canada)
  5.9.2 Chemotherapy Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Paladin Labs Inc. (Canada) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 ALZA Corporation (USA)
  5.10.2 Chemotherapy Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 ALZA Corporation (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Amgen Inc. (USA)
5.12 AstraZeneca PLC (UK)
5.13 Medimmune, LLC (USA)
5.14 Bristol-Myers Squibb Company (USA)
5.15 Cell Genesys Inc. (USA)
5.16 Dendreon Corporation (USA)
5.17 EUSA Pharma, (USA) Inc. (USA)
5.18 F. Hoffmann-La Roche Ltd. (Switzerland)
5.19 Progenics Pharmaceuticals, Inc. (USA)
5.20 Sanofi-Aventis SA (France)
5.21 Spectrum Pharmaceuticals, Inc. (USA)
5.22 Takeda Pharmaceutical Company Limited (Japan)

6 CHEMOTHERAPY MANUFACTURING COST ANALYSIS

6.1 Chemotherapy Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Chemotherapy

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Chemotherapy Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Chemotherapy Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA CHEMOTHERAPY MARKET FORECAST (2016-2021)

10.1 USA Chemotherapy Sales, Revenue Forecast (2016-2021)
10.2 USA Chemotherapy Sales Forecast by Type (2016-2021)
10.3 USA Chemotherapy Sales Forecast by Application (2016-2021)
10.4 Chemotherapy Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Chemotherapy
Table Classification of Chemotherapy
Figure USA Sales Market Share of Chemotherapy by Type in 2015
Table Application of Chemotherapy
Figure USA Sales Market Share of Chemotherapy by Application in 2015
Figure USA Chemotherapy Sales and Growth Rate (2011-2021)
Figure USA Chemotherapy Revenue and Growth Rate (2011-2021)
Table USA Chemotherapy Sales of Key Manufacturers (2015 and 2016)
Table USA Chemotherapy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Chemotherapy Sales Share by Manufacturers
Figure 2016 Chemotherapy Sales Share by Manufacturers
Table USA Chemotherapy Revenue by Manufacturers (2015 and 2016)
Table USA Chemotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Chemotherapy Revenue Share by Manufacturers
Table 2016 USA Chemotherapy Revenue Share by Manufacturers
Table USA Market Chemotherapy Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Chemotherapy Average Price of Key Manufacturers in 2015
Figure Chemotherapy Market Share of Top 3 Manufacturers
Figure Chemotherapy Market Share of Top 5 Manufacturers
Table USA Chemotherapy Sales by Type (2011-2016)
Table USA Chemotherapy Sales Share by Type (2011-2016)
Figure USA Chemotherapy Sales Market Share by Type in 2015
Table USA Chemotherapy Revenue and Market Share by Type (2011-2016)
Table USA Chemotherapy Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Chemotherapy by Type (2011-2016)
Table USA Chemotherapy Price by Type (2011-2016)
Figure USA Chemotherapy Sales Growth Rate by Type (2011-2016)
Table USA Chemotherapy Sales by Application (2011-2016)
Table USA Chemotherapy Sales Market Share by Application (2011-2016)
Figure USA Chemotherapy Sales Market Share by Application in 2015
Table USA Chemotherapy Sales Growth Rate by Application (2011-2016)
Figure USA Chemotherapy Sales Growth Rate by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Chemotherapy Sales Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (USA) Chemotherapy Sales Market Share (2011-2016)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Inc. (USA) Chemotherapy Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Chemotherapy Sales Market Share (2011-2016)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunomedics, Inc. (USA) Chemotherapy Sales Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Chemotherapy Sales Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG (Switzerland) Chemotherapy Sales Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Chemotherapy Sales Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Paladin Labs Inc. (Canada) Chemotherapy Sales Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information List
Table ALZA Corporation (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table ALZA Corporation (USA) Chemotherapy Sales Market Share (2011-2016)
Table Amgen Inc. (USA) Basic Information List
Table Amgen Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Inc. (USA) Chemotherapy Sales Market Share (2011-2016)
Table AstraZeneca PLC (UK) Basic Information List
Table AstraZeneca PLC (UK) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca PLC (UK) Chemotherapy Sales Market Share (2011-2016)
Table Medimmune, LLC (USA) Basic Information List
Table Medimmune, LLC (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medimmune, LLC (USA) Chemotherapy Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (USA) Basic Information List
Table Bristol-Myers Squibb Company (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (USA) Chemotherapy Sales Market Share (2011-2016)
Table Cell Genesys Inc. (USA) Basic Information List
Table Cell Genesys Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cell Genesys Inc. (USA) Chemotherapy Sales Market Share (2011-2016)
Table Dendreon Corporation (USA) Basic Information List
Table Dendreon Corporation (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon Corporation (USA) Chemotherapy Sales Market Share (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Basic Information List
Table EUSA Pharma, (USA) Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Chemotherapy Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Chemotherapy Sales Market Share (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List
Table Progenics Pharmaceuticals, Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Chemotherapy Sales Market Share (2011-2016)
Table Sanofi-Aventis SA (France) Basic Information List
Table Sanofi-Aventis SA (France) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi-Aventis SA (France) Chemotherapy Sales Market Share (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List
Table Spectrum Pharmaceuticals, Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Chemotherapy Sales Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Chemotherapy Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chemotherapy
Figure Manufacturing Process Analysis of Chemotherapy
Figure Chemotherapy Industrial Chain Analysis
Table Raw Materials Sources of Chemotherapy Major Manufacturers in 2015
Table Major Buyers of Chemotherapy
Table Distributors/Traders List
Figure USA Chemotherapy Production and Growth Rate Forecast (2016-2021)
Figure USA Chemotherapy Revenue and Growth Rate Forecast (2016-2021)
Table USA Chemotherapy Production Forecast by Type (2016-2021)
Table USA Chemotherapy Consumption Forecast by Application (2016-2021)